Duke Medicine has been awarded $15 million to support an innovative research program that explores the use of umbilical cord blood cells to treat autism, stroke, cerebral palsy and related brain disorders.
Joanne Kurtzberg and Geraldine Dawson hope to develop cell-based therapies that can potentially restore brain function in people with the disorders, for which there currently are no cures.
If successful, the study could identify therapies for further evaluation in clinical trials to potentially decrease disabilities and improve the quality of life for millions of children and adults.
The project will consist of a series of clinical trials using umbilical cord blood cells to treat a total of 390 children and adults with autism, 100 children with cerebral palsy and 90 adults with stroke. Based on previous research, Kurtzberg and Dawson hypothesise that cord blood may promote repair of dysfunctional or damaged areas of the brain.
This is just one of hundreds of clinical trials being conducted using cord blood stem cells to advance the quality of life for those with a wide range of conditions. There is only one chance to collect and store your baby’s powerful cord blood and tissue stem cells for potential future use – at birth.
This blog post is sponsored by Cell Care Australia – Australia’s largest and most experienced cord blood and tissue bank.